Alignment Healthcare, Inc. (NASDAQ:ALHC) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Alignment Healthcare, Inc. (NASDAQ:ALHC) has received an average consensus rating of "Moderate Buy" from eleven analysts, with an average 12-month price target of $18.83.
• Insider trading activity includes significant share sales by President Dawn Christine Maroney, who sold over 215,000 shares, resulting in a 10.71% decrease in her position.
• The company reported a 49% increase in revenue for the last quarter, totaling $1.02 billion, and beat earnings expectations by $0.14 per share.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $18.8333.

Several research analysts have recently issued reports on ALHC shares. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a report on Monday, August 25th. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Finally, Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 215,662 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the completion of the sale, the president owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. This trade represents a 10.71% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Robert L. Scavo sold 29,535 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $484,669.35. Following the completion of the sale, the insider owned 572,555 shares of the company's stock, valued at approximately $9,395,627.55. This trade represents a 4.91% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,388,173 shares of company stock worth $118,068,256. 6.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ALHC. Teacher Retirement System of Texas grew its position in Alignment Healthcare by 109.1% in the first quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company's stock worth $883,000 after acquiring an additional 24,755 shares in the last quarter. New York State Common Retirement Fund boosted its position in Alignment Healthcare by 100.9% during the first quarter. New York State Common Retirement Fund now owns 165,642 shares of the company's stock valued at $3,084,000 after buying an additional 83,187 shares during the period. Victory Capital Management Inc. boosted its position in Alignment Healthcare by 905.7% during the first quarter. Victory Capital Management Inc. now owns 114,397 shares of the company's stock valued at $2,130,000 after buying an additional 103,022 shares during the period. GAMMA Investing LLC boosted its position in Alignment Healthcare by 3,216.9% during the first quarter. GAMMA Investing LLC now owns 23,815 shares of the company's stock valued at $443,000 after buying an additional 23,097 shares during the period. Finally, Raymond James Financial Inc. boosted its position in Alignment Healthcare by 31.1% during the first quarter. Raymond James Financial Inc. now owns 206,174 shares of the company's stock valued at $3,839,000 after buying an additional 48,901 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Alignment Healthcare Stock Performance

ALHC opened at $17.45 on Wednesday. The business's 50-day moving average price is $15.32 and its two-hundred day moving average price is $15.66. Alignment Healthcare has a 1 year low of $9.15 and a 1 year high of $21.06. The company has a market capitalization of $3.46 billion, a price-to-earnings ratio of -62.32 and a beta of 1.17. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. During the same quarter last year, the company earned ($0.13) EPS. Alignment Healthcare's revenue for the quarter was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts expect that Alignment Healthcare will post -0.69 EPS for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.